Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maher Albitar

Showing results (81-90 of 214) with videos related to

Pageof 22
Sort By:
Neurological Research|June 20, 2012
Plasma ubiquitin-proteasome system profile in patients with multiple sclerosis: correlation with clinical features, neuroimaging, and treatment with interferon-beta-1bAlireza Minagar, Wanlong Ma, Xi Zhang, et al.
Cancer Chemotherapy and Pharmacology|August 31, 2002
Recombinant human soluble tumor necrosis factor (TNF) receptor (p75) fusion protein Enbrel in patients with refractory hematologic malignanciesApostolia-Maria Tsimberidou, Deborah Thomas, Susan O'Brien, et al.
The New England Journal of Medicine|February 14, 2009
B-cell clones as early markers for chronic lymphocytic leukemiaOla Landgren, Maher Albitar, Wanlong Ma, et al.
Cancer|May 13, 2004
The clinical significance of large cells in bone marrow in patients with chronic lymphocytic leukemiaYupo Ma, Adnan Mansour, B Nebiyou Bekele, et al.
The New England Journal of Medicine|March 8, 2002
Hepatocytes and epithelial cells of donor origin in recipients of peripheral-blood stem cellsMartin Körbling, Ruth L Katz, Abha Khanna, et al.
European Journal of Haematology|September 3, 2003
Molecular differences between small and large cells in patients with chronic lymphocytic leukemiaJeong N Lee, Fancis Giles, Yang O Huh, et al.
Scandinavian Journal of Urology|July 2, 2020
A prospective study of a urine and plasma biomarker test for the prediction of gleason ≥3 + 4 prostate cancer in a mixed cohortMads Hvid Poulsen, Søren Feddersen, Maher Albitar, et al.
Experimental Hematology|May 9, 2009
Proteomics-based prediction of clinical response in acute myeloid leukemiaMaher Albitar, Steven J Potts, Francis J Giles, et al.
British Journal of Haematology|November 18, 2003
Single agent thalidomide in patients with relapsed or refractory acute myeloid leukaemiaDeborah A Thomas, Elihu Estey, Francis J Giles, et al.
Blood|March 26, 2008
Higher detection rate of JAK2 mutation using plasmaWanlong Ma, Hagop Kantarjian, Xi Zhang, et al.
Pageof 22

Showing results (81-90 of 214) with videos related to

Sort By:
Pageof 22
Neurological Research|June 20, 2012
Plasma ubiquitin-proteasome system profile in patients with multiple sclerosis: correlation with clinical features, neuroimaging, and treatment with interferon-beta-1bAlireza Minagar, Wanlong Ma, Xi Zhang, et al.
Cancer Chemotherapy and Pharmacology|August 31, 2002
Recombinant human soluble tumor necrosis factor (TNF) receptor (p75) fusion protein Enbrel in patients with refractory hematologic malignanciesApostolia-Maria Tsimberidou, Deborah Thomas, Susan O'Brien, et al.
The New England Journal of Medicine|February 14, 2009
B-cell clones as early markers for chronic lymphocytic leukemiaOla Landgren, Maher Albitar, Wanlong Ma, et al.
Cancer|May 13, 2004
The clinical significance of large cells in bone marrow in patients with chronic lymphocytic leukemiaYupo Ma, Adnan Mansour, B Nebiyou Bekele, et al.
The New England Journal of Medicine|March 8, 2002
Hepatocytes and epithelial cells of donor origin in recipients of peripheral-blood stem cellsMartin Körbling, Ruth L Katz, Abha Khanna, et al.
European Journal of Haematology|September 3, 2003
Molecular differences between small and large cells in patients with chronic lymphocytic leukemiaJeong N Lee, Fancis Giles, Yang O Huh, et al.
Scandinavian Journal of Urology|July 2, 2020
A prospective study of a urine and plasma biomarker test for the prediction of gleason ≥3 + 4 prostate cancer in a mixed cohortMads Hvid Poulsen, Søren Feddersen, Maher Albitar, et al.
Experimental Hematology|May 9, 2009
Proteomics-based prediction of clinical response in acute myeloid leukemiaMaher Albitar, Steven J Potts, Francis J Giles, et al.
British Journal of Haematology|November 18, 2003
Single agent thalidomide in patients with relapsed or refractory acute myeloid leukaemiaDeborah A Thomas, Elihu Estey, Francis J Giles, et al.
Blood|March 26, 2008
Higher detection rate of JAK2 mutation using plasmaWanlong Ma, Hagop Kantarjian, Xi Zhang, et al.
Pageof 22